- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.03. | Insilico raises $110m for AI-designed drug pipeline | ||
| 13.03. | 'Transformational' pill for endometriosis gets NHS nod | ||
| 13.03. | Rumour confirmed as Mallinckrodt merges with Endo | ||
| 13.03. | UK PM Keir Starmer reveals plan to abolish NHS England | ||
| 13.03. | Is Mallinckrodt about to merge with Endo? | ||
| 13.03. | Kelun-Biotech first to bag TROP2 approval in lung cancer | ||
| 12.03. | Roche builds in obesity with $5.3bn Zealand Pharma licensing deal | ||
| 12.03. | Gates-backed game aims to raise HPV awareness in Africa | ||
| 12.03. | EU proposes legislation to bolster medicines supply chain | ||
| 12.03. | Merck KGaA's MS tablet set for wider use by NHS in England | ||
| 12.03. | MSD opens $1bn plant for HPV vaccine in the US | ||
| 11.03. | Pfizer's new drug data in breast cancer draws muted response | ||
| 11.03. | Scientific 'superintelligence' firm Lila launches with $200m | ||
| 11.03. | J&J abandons work with Genmab on Darzalex successor | ||
| 11.03. | NHS England facing major job losses to reduce DHSC 'overlap' | ||
| 11.03. | BMS absorbs CAR-T partner 2seventy bio for $286m | ||
| 10.03. | EU clears AZ, Ionis' Wainzua for ATTR polyneuropathy | ||
| 10.03. | Beam launches $500m financing on base-editing trial data | ||
| 10.03. | Novo Nordisk's CagriSema data disappoints investors again | ||
| 10.03. | J&J shows its confidence in oral IL-23 drug for psoriasis | ||
| 10.03. | Sun Pharma buys Checkpoint and its new cancer drug | ||
| 07.03. | Neurotech's cell therapy gets FDA nod for eye disorder MacTel | ||
| 07.03. | One of J&J's blockbuster depression hopes has flamed out | ||
| 07.03. | Denali's ALS programme suffers another setback | ||
| 07.03. | Biogen, Apple study finds smart devices can track cognition |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
